82 related articles for article (PubMed ID: 8139096)
1. [Blast self-renewal capacity as a target of the treatment in acute myelocytic leukemia].
Nara N
Rinsho Ketsueki; 1994 Jan; 35(1):1-8. PubMed ID: 8139096
[No Abstract] [Full Text] [Related]
2. Self-renewal capacity of leukemic blast progenitor cells.
Buick RN; Chang LJ; Messner HA; Curtis JE; McCulloch EA
Cancer Res; 1981 Nov; 41(11 Pt 2):4849-52. PubMed ID: 6945908
[TBL] [Abstract][Full Text] [Related]
3. [Proliferation and differentiation of leukemic cells in acute myelocytic leukemia].
Nara N
Rinsho Byori; 1998 May; 46(5):424-9. PubMed ID: 9627492
[TBL] [Abstract][Full Text] [Related]
4. Blast colony formation in myelogenous leukemia: drug sensitivity and renewal capacity of the leukemic clone.
Buick RN
Prog Clin Biol Res; 1980; 48():53-61. PubMed ID: 6937882
[No Abstract] [Full Text] [Related]
5. The cellular basis of self renewal in culture by human acute myeloblastic leukemia blast cell progenitors.
Chang LJ; Till JE; McCulloch EA
J Cell Physiol; 1980 Feb; 102(2):217-22. PubMed ID: 6929277
[TBL] [Abstract][Full Text] [Related]
6. Effect of vesnarinone, a quinolinone derivative, on the growth of leukemic blasts in acute myelogenous leukemia.
Nara N; Kurokawa H; Tohda S; Tomiyama J; Nagata K; Tanikawa S
Exp Hematol; 1997 Mar; 25(3):199-204. PubMed ID: 9091294
[TBL] [Abstract][Full Text] [Related]
7. Systems used to study the nature of the leukemic cell and predict treatment outcome in patients with myeloproliferative disorders.
Goldberg J
Clin Lab Med; 1990 Dec; 10(4):809-24. PubMed ID: 2272175
[TBL] [Abstract][Full Text] [Related]
8. Experimental basis of antileukaemic chemotherapy.
Messner HA
Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():20-5. PubMed ID: 2653504
[No Abstract] [Full Text] [Related]
9. Changes in self-renewal potential of human leukemic cells (K562): a bidirectional stochastic process.
von Mechner H; Höffken K
J Cell Physiol; 1985 May; 123(2):249-56. PubMed ID: 3856568
[TBL] [Abstract][Full Text] [Related]
10. Acute myeloid leukemia originates from a hierarchy of leukemic stem cell classes that differ in self-renewal capacity.
Hope KJ; Jin L; Dick JE
Nat Immunol; 2004 Jul; 5(7):738-43. PubMed ID: 15170211
[TBL] [Abstract][Full Text] [Related]
11. [Comparison of blast cell sensitivity to low-intensity laser radiation and chemotherapeutic drugs].
Karu TI; Riabykh TP; Sidorova TA; Dobrynin IaV
Dokl Akad Nauk; 1997 Mar; 353(1):114-7. PubMed ID: 9273047
[No Abstract] [Full Text] [Related]
12. [Prediction of the response to chemotherapy in acute leukemia through in-vitro incorporation of tritiated thymidine].
Zittoun R; Bouchard M; Facquet-Danis J; Percie-Du-Sert M; Bousser J
Ann Med Interne (Paris); 1974 Nov; 125(11):811-6. PubMed ID: 4618066
[No Abstract] [Full Text] [Related]
13. [Pharmacology and pharmacodynamics of various antitumor medications and the development of new treatment protocols].
Haanen C
Verh K Acad Geneeskd Belg; 1986; 48(2):65-83. PubMed ID: 3463012
[No Abstract] [Full Text] [Related]
14. Induction of differentiation of acute promyelocytic leukemia cells by a cytidine deaminase-resistant analogue of 1-beta-D-arabinofuranosylcytosine, 1-(2-deoxy-2-methylene-beta-D-erythro-pentofuranosyl)cytidine.
Niitsu N; Ishii Y; Matsuda A; Honma Y
Cancer Res; 2001 Jan; 61(1):178-85. PubMed ID: 11196157
[TBL] [Abstract][Full Text] [Related]
15. Retinoid receptor expression and its correlation to retinoid sensitivity in non-M3 acute myeloid leukemia blast cells.
Lehmann S; Paul C; Törmä H
Clin Cancer Res; 2001 Feb; 7(2):367-73. PubMed ID: 11234892
[TBL] [Abstract][Full Text] [Related]
16. 20-Cyclopropyl-cholecalciferol vitamin D3 analogs: a unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines.
Koike M; Koshizuka K; Kawabata H; Yang R; Taub HE; Said J; Uskokovic M; Tsuruoka N; Koeffler HP
Anticancer Res; 1999; 19(3A):1689-97. PubMed ID: 10470102
[TBL] [Abstract][Full Text] [Related]
17. Blocking the APRIL circuit enhances acute myeloid leukemia cell chemosensitivity.
Bonci D; Musumeci M; Coppola V; Addario A; Conticello C; Hahne M; Gulisano M; Grignani F; De Maria R
Haematologica; 2008 Dec; 93(12):1899-902. PubMed ID: 18838478
[TBL] [Abstract][Full Text] [Related]
18. Vesnarinone exhibits antitumor effect against myeloid leukemia cells via apoptosis.
Fujiwara H; Arima N; Otsubo H; Matsushita K; Hidaka S; Arimura K; Kukita T; Yamaguchi K; Tanaka H
Exp Hematol; 1997 Oct; 25(11):1180-6. PubMed ID: 9328455
[TBL] [Abstract][Full Text] [Related]
19. A diphtheria toxin-interleukin 3 fusion protein is cytotoxic to primitive acute myeloid leukemia progenitors but spares normal progenitors.
Feuring-Buske M; Frankel AE; Alexander RL; Gerhard B; Hogge DE
Cancer Res; 2002 Mar; 62(6):1730-6. PubMed ID: 11912147
[TBL] [Abstract][Full Text] [Related]
20. [Hematopoietic growth factors and blast progenitors in acute leukemia].
Miyauchi J
Rinsho Ketsueki; 1999 Aug; 40(8):617-29. PubMed ID: 10496036
[No Abstract] [Full Text] [Related]
[Next] [New Search]
